FNY Partners Fund’s Globus Medical GMED Stock Holding History

FNY Partners Fund’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,000	Closed	-$248	–	1461
2016 Q4	$248	Buy	+10,000	New	+$227K	0.01%	142

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FNY Partners Fund's GMED Position: Q1 2017 in Review

FNY Partners Fund sold out of Globus Medical (GMED) in Q1 2017, closing a stake of 10,000 shares — an estimated $248 sold.

FNY Partners Fund first reported a position in GMED in Q4 2016 and held it in 1 quarter. The position peaked at $248 in Q4 2016. 243 funds tracked by Wall St. Rank hold GMED as of Q1 2017.

FNY Partners Fund reported no remaining Globus Medical position as of Q1 2017 after selling out during the quarter.
FNY Partners Fund sold 10,000 Globus Medical shares in Q1 2017, an estimated $248.
FNY Partners Fund first reported a position in Globus Medical in Q4 2016 and held it in 1 quarter.
FNY Partners Fund's Globus Medical position peaked at $248 in Q4 2016.
243 funds tracked by Wall St. Rank held Globus Medical as of Q1 2017.

Based on FNY Partners Fund's 13F filing for Q1 2017, filed 15 May 2017.